Big Tech & Digital Health

Amazon Puts Amwell Co-Founder in Charge of Healthcare Unit

By Intent.Health Team May 28, 2026
Intent Health AI Data Flow

What’s happening

Amazon appointed an Amwell co-founder to lead its healthcare division after a longtime executive departed.

The appointment signals Amazon’s continued push into:

What’s changing / Business impact

This organizational realignment introduces new tactical shifts for tech-driven care:

Why this matters

Amazon has spent years trying to establish a beachhead in healthcare but has faced persistent organizational challenges successfully scaling its healthcare business operations.

This aggressive executive hire shows that big tech still views healthcare as a massive, non-negotiable long-term commercial opportunity, proving that leadership changes may signal major strategic restructuring.
Pharma & R&D

FDA Approves MannKind’s Inhaled Insulin for Children

By Intent.Health Team May 29, 2026
Intent Health AI Data Flow

What’s happening

The FDA approved MannKind Corporation's inhaled insulin for children with diabetes.

The treatment allows insulin to be inhaled rather than injected, providing another option for young patients who may struggle with regular injections.

What’s changing / Business impact

The approval expands treatment options in pediatric diabetes care and could increase adoption of alternative insulin delivery methods.

Why this matters

Many children dislike or fear frequent injections. Alternative delivery systems may improve treatment adherence and quality of life.